Up
2006P-0309:
ANDA for ELOXATIN (oxaliplatin for injection) lLyophilized Powder
for Infusion, 50 mg and 100 mg Vials
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
ACK1 |
|
08/07/2006
|
|
08/07/2006
|
|
Federal Government |
|
FDA/DDMB to
Frommer, Lawrence & Haug, LLP |
|
|
|
|
|
|
|
pdf |
|
|
|
|
|
|
Signature: |
|
Gloria Ortega |
|
|
|
CP1 |
|
08/07/2006
|
|
08/07/2006
|
|
Private Industry
|
|
Frommer, Lawrence
& Haug, LLP |
|
|
|
|
|
|
|
Table
of Contents |
|
|
|
|
Signature: |
|
Charles J. Raubicheck
|
|
Top | Up
Page last updated
August 25, 2006
kk![horizonal rule](https://webarchive.library.unt.edu/eot2008/20090118093345im_/http://www.fda.gov/graphics/blkpixel.gif)
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |